Drug class
Centrally acting antimuscarinic agent; antiparkinsonian anticholinergic
Mechanism of action
Antagonises central muscarinic acetylcholine receptors, restoring the relative balance between cholinergic and dopaminergic activity in basal-ganglia motor pathways and reducing tremor and rigidity.
General use cases
- Symptomatic treatment of Parkinsonism in countries where biperiden is authorised
- Treatment of selected drug-induced extrapyramidal symptoms, such as acute dystonic reactions, where included in local product information
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
